Gimme Care vs Ivy Rx

Neither Gimme Care nor Ivy Rx has an FDA warning letter on record. On compounded tirzepatide injection, Gimme Care costs $1,176 less a year at standing rates: $199 a month against $297 a month at Ivy Rx. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor

Editorially reviewed. Not medical advice · How we verify contentLast reviewed October 2026

The record

Gimme Care / Ivy Rx

Gimme Care

8.5/10

Ivy Rx

7.3/10

FDA warning letters

None on record

Pharmacy

None named in our record

Lowest standing price

$160/moCompounded semaglutide injection

$197/moCompounded semaglutide injection

States

All 50 states and DC

All 50 states

Checked

Prices captured October 17, 2026Record checked October 2026

Prices captured July 10, 2026Record checked October 2026

Visit Gimme Care

Visit Ivy Rx

Neither Gimme Care nor Ivy Rx pays us. Links to them earn nothing. Scores: Gimme Care 8.5, Ivy Rx 7.3. How we are paid

What the record shows

01
Neither Gimme Care nor Ivy Rx has an FDA warning letter on record.
02
Neither names the pharmacy that compounds its medication.
03
On compounded tirzepatide injection, Gimme Care costs $1,176 less a year at standing rates: $199 a month against $297 a month at Ivy Rx. It is one of two products the two sell at comparable terms.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Gimme Care

Ivy Rx

Compounded semaglutide injection

$160/moLower

$1,920 a year

$197/mo

$2,364 a year

Compounded tirzepatide injection

$199/moLower

$2,388 a year

$297/mo

$3,564 a year

Price includes

Medication, clinician visits, shipping

Cancel any time

Yes, stated

Minimum term

None on the monthly cycle

None

Refunds

Full refund if canceled before the pharmacy ships; dispensed medication is final sale

All transactions are final; no returns

Early-exit fee

None stated

Read off each seller’s own pages. Gimme Care: October 17, 2026. Ivy Rx: July 10, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Gimme Care

8.5/10

$444 a year less on compounded semaglutide injection
$1,176 a year less on compounded tirzepatide injection

Names no compounding pharmacy

Visit Gimme Care

The case for Ivy Rx

7.3/10

The record gives Ivy Rx no edge on this pair.

Names no compounding pharmacy

Visit Ivy Rx

Scores

Gimme Care 8.5 · Ivy Rx 7.3 out of 10. Six weighted parts.

Value25%

7.2

3.0

Effectiveness25%

10.0

User Experience15%

8.0

Trust & Safety15%

8.5

7.5

Accessibility10%

10.0

Support10%

7.0

The score is the same formula for every seller. Payment does not enter it. Method

Gimme Care vs Ivy Rx: questions

Neither Gimme Care nor Ivy Rx has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.

Neither names the pharmacy that compounds its medication.

Gimme Care, by $444 a year at standing rates. Gimme Care: $160 a month, about $1,920 a year. Ivy Rx: $197 a month, about $2,364 a year.

Gimme Care states you can cancel at any time; refunds: full refund if canceled before the pharmacy ships; dispensed medication is final sale. Ivy Rx states you can cancel at any time; refunds: all transactions are final; no returns.

Neither Gimme Care nor Ivy Rx pays us. Links to them earn nothing. Scores: Gimme Care 8.5, Ivy Rx 7.3.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Eden8.7
From $99/mo
Visit site
YourEra9.0
From $99/mo
Visit site
Gala8.5
From $179/mo
Visit site

Matched on molecule, form and price. Every pair we list · The register